40 / 48
androgen levels in men: impact of health status
and age. Urology 2003;61: 629-33.
7. Morales A, Lunenefeld B. International
Society for the Study of the Aging Male.
Investigation, treatment and monitoring of late-
onset hypogonadism in males. Official
recommendation of ISSAM. International
Society for the study of the Aging Male. Aging
Male 2002:74-86.
8.
Corona G, Mannucci E, Petrone L, Balercia
G, Fisher AD, Chiarini V, et al ANDROTEST: a
structured interview for the screening of
hypogonadism in patient with sexual
dysfunction. J Sex Med 2006;3:706-15.
9. Martínez-Jabaloyas JM, Queipo-Zaragozá A,
Pastor-Hernández F, Gil-SalomM, Chuan-Nuez
P. Testosterone levels in men with erectile
dysfunction. BJU Int 2006;97:1278-83.
10.
Hintikka J, Niskanen L, Koivumaa-
Honkanen H, Tolmunen T, Honkalampi K,
Lehto SM, et al.Hypogonadism, decreased
sexual desire and long term depression in
middle-aged men.J Sex Med 2009;6:2049-57.
11.
Vermeulen A, Goermarere S, Kaufman M.
Sex hormones, body composition and aging.
Aging Male 1999;2;8-15.
12.
Corona G, Mannucci E, Petrone L,
Schulman C, Balercia G, Fisher AD, et al. A
comparison ofNCEP-ATP III and IDF metabolic